Core Viewpoint - A class action lawsuit has been filed against Integer Holdings Corporation and its senior executives for securities fraud following a significant drop in stock price due to alleged violations of federal securities laws [2][4]. Group 1: Lawsuit Details - The lawsuit is pending in the U.S. District Court for the Southern District of New York, titled West Palm Beach Firefighters' Pension Fund v. Integer Holdings Corporation, et al., No. 1:25-cv-10251 [4]. - Investors have until February 9, 2026, to request to lead the case [4]. Group 2: Company Performance and Allegations - Integer designs and manufactures cardiac rhythm management and cardiovascular products, including electrophysiology devices [5]. - The company allegedly overstated demand for its electrophysiology devices while public assurances contradicted the actual decline in demand and revenue [6][5]. Group 3: Stock Price Impact - On October 23, 2025, Integer lowered its 2025 sales guidance to between $1.840 billion and $1.854 billion, down from $1.850 billion to $1.876 billion, which was below analysts' expectations [7]. - The company projected poor net sales growth of -2% to 2% and organic sales growth of 0% to 4% for 2026, admitting that two of its EP devices had slower than expected adoption [7]. - Following this announcement, Integer's stock price fell by $35.22 per share, a decrease of over 32%, from $109.11 on October 22, 2025, to $73.89 on October 23, 2025 [7].

Core Viewpoint - The Integer Holdings Corporation is facing a class action lawsuit for allegedly making false statements and failing to disclose critical information regarding its competitive position and sales performance in the electrophysiology market, leading to significant stock price declines [3][4]. Company Overview - Integer Holdings operates as a medical device contract development and manufacturing company [2]. Allegations of the Lawsuit - The lawsuit claims that Integer Holdings overstated its competitive position in the electrophysiology manufacturing market [3]. - It is alleged that the company experienced a deterioration in sales for two of its electrophysiology devices, contrary to its claims of strong customer demand [3]. - The company mischaracterized its electrophysiology devices as long-term growth drivers for its Cardio & Vascular segment [3]. Financial Performance and Guidance - On October 23, 2025, Integer Holdings lowered its full-year 2025 sales guidance, which was below analysts' expectations [4]. - The company projected net sales growth of -2% to 2% and organic sales growth of 0% to 4% for the full year of 2026 [4]. - Following the announcement, the stock price of Integer Holdings fell by more than 32% [4]. Lead Plaintiff Process - The Private Securities Litigation Reform Act of 1995 allows any investor who purchased Integer Holdings common stock during the class period to seek appointment as lead plaintiff in the lawsuit [5]. - The lead plaintiff represents the interests of all class members and can select a law firm to litigate the case [5]. Law Firm Background - Robbins Geller Rudman & Dowd LLP is a leading law firm specializing in securities fraud and shareholder litigation, having recovered over $2.5 billion for investors in 2024 alone [6]. - The firm has been ranked 1 in securing monetary relief for investors in securities class action cases for four out of the last five years [6].

Core Points - A class action has been filed against Integer Holdings Corporation (ITGR) on behalf of investors who acquired its securities between July 25, 2024, and October 22, 2025, alleging misleading information regarding the company's market position and product demand [1][2] - The complaint claims that Integer Holdings overstated the demand for its electrophysiology (EP) devices, while in reality, demand had significantly decreased, contradicting the company's claims of outpacing market growth [2] - On October 23, 2025, Integer revised its full-year 2025 guidance, expecting net sales growth of -2% to 2% and organic sales growth of 0% to 4% for 2026, leading to a stock price drop of over 32% [3] Allegations and Impact - The allegations suggest that Integer Holdings misled investors about the demand for its EP devices, which has been declining rather than growing as claimed [2] - The company's admission of slower market adoption for two of its EP devices has raised concerns about continued demand issues into 2026 [3] - Following the announcement of revised guidance, Integer's stock fell by $35.22 per share, closing at $73.89 on October 23, 2025, indicating a significant loss in investor confidence [3] Legal Proceedings - Shareholders interested in participating in the class action must submit their papers by February 9, 2026, to serve as lead plaintiff, representing the interests of other class members [4] - Shareholders are not required to participate in the case to be eligible for recovery, allowing them to remain absent class members if they choose [4]

NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Kahn Swick & Foti, LLC ("KSF†) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with substantial losses that they have until February 9, 2026 to file lead plaintiff applications in a securities class action lawsuit against Integer Holdings Corporation ("Integer†or the "Company†) (NYSE: ITGR), if they purchased or otherwise acquired the Company's shares between July 25, 2024 and October 22, 2025, inclusive (the "Class P ...

Core Viewpoint - Integer Holdings Corporation is facing a class action lawsuit for allegedly making false statements and failing to disclose critical information regarding its competitive position and sales performance in the electrophysiology market [3][4]. Group 1: Class Action Lawsuit Details - The class action lawsuit is titled West Palm Beach Firefighters' Pension Fund v. Integer Holdings Corporation and covers purchasers of Integer Holdings common stock from July 25, 2024, to October 22, 2025 [1]. - Investors have until February 9, 2026, to seek appointment as lead plaintiff in the lawsuit [1][5]. - The lawsuit alleges that Integer Holdings overstated its competitive position and misrepresented the sales performance of its electrophysiology devices [3]. Group 2: Allegations and Financial Impact - The lawsuit claims that Integer Holdings experienced a deterioration in sales for two of its electrophysiology devices, contradicting its claims of strong customer demand [3]. - On October 23, 2025, Integer Holdings lowered its full-year 2025 sales guidance, which was below analysts' expectations, and projected net sales growth of -2% to 2% for 2026 [4]. - Following the announcement, the stock price of Integer Holdings fell by more than 32% [4]. Group 3: Company Background - Integer Holdings operates as a medical device contract development and manufacturing company [2]. - The company is involved in the electrophysiology market, which is experiencing growth, but Integer Holdings' position within this market has been called into question [3].

All representation is on a contingency fee basis. Shareholders pay no fees or expenses. NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of Integer Holdings Corporation (NYSE: ITGR) common stock between July 25, 2024 and October 22, 2025, both dates inclusive (the "Class Period†). Integer is a medical device contract manufacturer. For more information, submit a form, email attorney Phillip Kim, or give us a call at 866-7 ...

Core Viewpoint - A class action lawsuit has been filed against Integer Holdings Corporation and certain senior executives for securities fraud following a significant stock drop due to potential violations of federal securities laws [1][3]. Company Overview - Integer Holdings Corporation specializes in designing and manufacturing cardiac rhythm management and cardiovascular products, including electrophysiology devices that diagnose and treat arrhythmias [4]. Allegations - The lawsuit claims that Integer misrepresented the demand and revenue for its electrophysiology products, which had actually fallen sharply, contradicting the company's public statements about sales growth and market position [4][5]. Stock Performance - On October 23, 2025, Integer revised its 2025 sales guidance down to between $1.840 billion and $1.854 billion, significantly below analysts' expectations. The company also projected poor net sales growth of -2% to 2% and organic sales growth of 0% to 4% for 2026. This announcement led to a stock price drop of $35.22 per share, over 32%, from $109.11 to $73.89 [6].

Core Viewpoint - Grabar Law Office is investigating claims against Integer Holdings, Corp. regarding potential breaches of fiduciary duties by certain officers and directors [1][3]. Group 1: Investigation Details - The investigation focuses on whether officers and directors of Integer Holdings, Corp. breached their fiduciary duties to the company [1]. - Shareholders who purchased shares prior to July 25, 2024, and still hold them can seek corporate reforms and the return of funds at no cost [2][4]. Group 2: Allegations of Misconduct - A federal securities fraud class action complaint alleges that Integer Holdings made materially false and misleading statements about its business and operations [3]. - Specific allegations include: 1. Integer overstated its competitive position in the EP manufacturing market [3]. 2. The company experienced a deterioration in sales for two of its EP devices, contrary to claims of strong customer demand [3]. 3. Integer mischaracterized its EP devices as long-term growth drivers for its C&V segment [3]. 4. Positive statements made by the defendants about the company's prospects were materially false and lacked a reasonable basis [3].

Core Viewpoint - A class action lawsuit has been filed against Integer Holdings Corporation and certain officers for alleged violations of federal securities laws during the Class Period from July 25, 2024, to October 22, 2025 [1][2]. Summary by Sections Lawsuit Details - The lawsuit seeks to recover damages for all individuals and entities that purchased or acquired Integer securities during the specified Class Period [2]. - The Complaint alleges that Defendants made materially false and misleading statements and failed to disclose adverse facts about the Company's business and operations [3]. Allegations Against Integer - Integer allegedly overstated its competitive position in the expanding EP manufacturing market [8]. - Despite claims of strong visibility into customer demand, the Company was reportedly experiencing a decline in sales related to two of its EP devices [8]. - Integer mischaracterized its EP devices as a long-term growth driver for its C&V segment [8]. - Consequently, the positive statements made by Defendants regarding the Company's business and prospects were deemed materially false and misleading [8]. Investor Information - Investors who suffered losses in Integer have until February 9, 2026, to request appointment as lead plaintiff [3]. - The law firm representing the investors operates on a contingency fee basis, meaning they will only recover costs if successful [4]. Firm Background - Bronstein, Gewirtz & Grossman, LLC is recognized for representing investors in securities fraud class actions and has recovered hundreds of millions for investors [5]. - The firm emphasizes restoring investor capital and ensuring corporate accountability to maintain market integrity [5].

NEW YORK--(BUSINESS WIRE)---- $ITGR #BFA--Integer Holdings Corporation Lowered Sales Outlook Triggers Securities Fraud Class Action after Stock Drops Over 32% -- Investors Urged to Contact BFA. ...